| 2 | CD226 Deletion Reduces Type 1 Diabetes in the NOD Mouse by Impairing Thymocyte Development and Peripheral T Cell Activation. (Shapiro MR, Yeh WI, Longfield JR, Gallagher J, Infante CM, Wellford S, Posgai AL, Atkinson MA, Campbell-Thompson M, Lieberman SM, Serreze DV, Geurts AM, Chen YG, Brusko TM) Front Immunol 2020;11:2180 17 Citations |
| 2 | Evidence for a stepwise program of extrathymic T cell development within the human tonsil. (McClory S, Hughes T, Freud AG, Briercheck EL, Martin C, Trimboli AJ, Yu J, Zhang X, Leone G, Nuovo G, Caligiuri MA) J Clin Invest 2012 Apr;122(4):1403-15 71 Citations |
| 1 | Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice. (Li J, Semple K, Suh WK, Liu C, Chen F, Blazar BR, Yu XZ) Biol Blood Marrow Transplant 2011 Jul;17(7):962-9 41 Citations |
| 1 | Trafficking, persistence, and activation state of adoptively transferred allogeneic and autologous Simian Immunodeficiency Virus-specific CD8(+) T cell clones during acute and chronic infection of rhesus macaques. (Bolton DL, Minang JT, Trivett MT, Song K, Tuscher JJ, Li Y, Piatak M Jr, O'Connor D, Lifson JD, Roederer M, Ohlen C) J Immunol 2010 Jan 01;184(1):303-14 33 Citations |
| 1 | CD28 controls differentiation of regulatory T cells from naive CD4 T cells. (Guo F, Iclozan C, Suh WK, Anasetti C, Yu XZ) J Immunol 2008 Aug 15;181(4):2285-91 95 Citations |
| 1 | Cellular immune response to an engineered cell-based tumor vaccine at the vaccination site. (Zhou Q, Johnson BD, Orentas RJ) Cell Immunol 2007 Feb;245(2):91-102 5 Citations |
| 1 | Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells. (Yu XZ, Liang Y, Nurieva RI, Guo F, Anasetti C, Dong C) J Immunol 2006 Jun 15;176(12):7394-401 43 Citations |
| 1 | T-cell tolerance or function is determined by combinatorial costimulatory signals. (Nurieva R, Thomas S, Nguyen T, Martin-Orozco N, Wang Y, Kaja MK, Yu XZ, Dong C) EMBO J 2006 Jun 07;25(11):2623-33 202 Citations |
| 1 | Functional reprogramming of the primary immune response by T cell receptor antagonism. (Haribhai D, Edwards B, Williams ML, Williams CB) J Exp Med 2004 Dec 06;200(11):1371-82 10 Citations |
| 1 | Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation. (Truitt RL, Johnson BD, Hanke C, Talib S, Hearst JE) J Immunol 1999 Nov 01;163(9):5145-56 48 Citations |
| 1 | Differential quantitative effects of interleukin (IL)-2 and IL-15 on cytotoxic activity and proliferation by lymphocytes from patients receiving in vivo IL-2 therapy. (de Jong JL, Farner NL, Javorsky BR, Lindstrom MJ, Hank JA, Sondel PM) Clin Cancer Res 1998 May;4(5):1287-96 11 Citations |
| 1 | Regulation of lymphokine-activated killer activity in T-replete and T-cell-depleted human bone marrow by interleukin 4. (Drobyski WR, LeFever AV, Truitt RL) Exp Hematol 1991 Oct;19(9):950-7 1 Citation |
| 1 | Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow. (Drobyski WR, Piaskowski V, Ash RC, Casper JT, Truitt RL) Transplantation 1990 Oct;50(4):625-32 17 Citations |
| 1 | Dinucleotide repeat polymorphisms at the D11S419 and CD3D loci. (Weber JL, Kwitek AE, May PE) Nucleic Acids Res 1990 Jul 11;18(13):4036 30 Citations |
| 1 | Human immunodeficiency virus-1 disease progression in hemophiliacs. (Becherer PR, Smiley ML, Matthews TJ, Weinhold KJ, McMillan CW, White GC 2nd) Am J Hematol 1990 Jul;34(3):204-9 38 Citations |
| 1 | The classical and alternate pathways of T cell activation are impaired in leprosy. (Muthukkaruppan V, Chakkalath HR, Malarkannan S) Immunol Lett 1988 Sep;19(1):55-8 4 Citations |
| 1 | An immunogenetic study of suppressor cell activity in autoimmune chronic active hepatitis. (Krawitt EL, Kilby AE, Albertini RJ, Schanfield MS, Chastenay BF, Harper PC, Mickey RM, McAuliffe TL) Clin Immunol Immunopathol 1988 Feb;46(2):249-57 14 Citations |
© 2024 Clinical & Translational Science Institute